That's crucial, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be efficient. Simply put, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental process (future report). Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. This was an advancement practically no one noticed. However it's going to have extensive implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of financial investment chances in this space, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (exponential growth). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps significantly before going greater - future report. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. However that's not the huge question anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. brownstone research stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many great private business on the verge of hitting the general public markets And I have actually been working on a new method for you to invest even before these companies go public.
This chance has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to book your spot free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers know that tech isn't our normal beat (jeff brown biotech genome sequencing). And when it comes to tech investing, we leave it to the experts. Luckily, we have a number of such experts in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing specialists we know (democratic republic). In reality, he had several triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and forecast what's just around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and much more. These trends are experiencing exponential development and developing amazing opportunities for investors. I desire to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. white house. However despite what numerous readers might believe, this is a trend that's just starting. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown investor prediction). Losing 2 months of production and sales actually affects how numerous 5G devices are offered in the calendar year. When you think about all of that, selling 250 million systems is amazing. More significantly, the delays brought on by the pandemic created a lots of pent-up need. And that need is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G devices will be delivered in 2021 - legacy report prediction. Which's not my only 5G prediction When I have actually talked about 5G in the past, I've described its 3 various phases.
In Stage 2, 5G devices go on sale. 5G phones and other products begin to reach consumers. And in Stage 3, 5G services begin to be used (brownstone research stock). That's when we start to see applications operating on 5G networks. Think about things like enormous multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase 3 by this summer. This starts something of a virtuous cycle: Many people do not actually appreciate the technology. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In reality, 5G is going to open a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances moving forward will be massive. Stepping away from 5G, the next essential technology I foresee in 2021 is CRISPR genetic modifying. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software application.
The program can crash or not work properly. CRISPR uses a comparable concept however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For years, CRISPR was mostly a niche innovation that wasn't well comprehended. And throughout that time, there were truly only 3 companies running in this space. However things are altering. CRISPR is no longer just theoretical. We're seeing real results. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This whole industry is efficiently a greenfield chance.
There's space for lots of business to exist in this space. jeff brown 1 biotech. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or 3 more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software application can precisely forecast the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That is necessary since the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're created to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug treatments produced using this technology. This was among those breakthroughs that almost nobody noticed. However it's going to have profound ramifications for curing illness. And, obviously, there will be a lot of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it pulled back perhaps considerably prior to going greater. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin - longtime readers. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. last year. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the information is up to date since February 2021, but we could not separately confirm this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to pick winning innovation stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an outstanding point of view on the marketplace. He's always on the hunt for brand-new opportunities, and he shares numerous of his finest choices in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he successfully anticipated a few of the most significant economic occasions of the past 20 years. Although he does not appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it best every time, however Jeff Brown's precise predictions have made him legions of devoted fans. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a prominent financial research study publisher. Brownstone Research study offers numerous research study services with a wide range of specializations - korean actress.
The business is likewise associated with Bonner & Partners, another well-respected research study publisher - last week. On its site, Brownstone says its mission is to supply retail financiers with professional-grade research: "For too long, the best financial investment research has actually not been available to private financiers. It has actually been generally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth customers. black sea. The objective of Brownstone Research study is to make that type of exclusive research study offered to any financiers looking to acquire an edge in the marketplaces. The objective is easy to provide unique and profitable investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also acts as the firm's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After years of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you understand even a little bit about the marketplace, you understand that he has a track record as a King Midas of sorts. jeff brown 2021 stock predictions. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown believes S.A.V. tech stocks. could be "the most significant trend of the 2020s, and he's not alone. Examine out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding 2 innovative innovations: expert system and electric automobiles. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the automobile market's Holy Grail. As you understand, electric cars and self-driving vehicle stocks have been huge this year, but the Wall Street device has been huge on buzz without much concrete outcome. In spite of an extreme increase in competition over the previous couple of years, Brown still believes Musk has the very best possibility of putting everything together.
tech could be the magic string that connects everything together. S.A.V. represents Shared Autonomous Vehicle, and it might be the future of transportation. Basically, this technology would allow you to rent your car as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the cars and truck and press a button on an app that informs the car to "join the fleet." Next thing you understand, you're relaxing on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a large piece of the profits. It sounds insane, however it might be closed than you believe.